These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24043274)

  • 21. Lentiviral vector-mediated RBM5 overexpression downregulates EGFR expression in human non-small cell lung cancer cells.
    Su Z; Yin J; Zhao L; Li R; Liang H; Zhang J; Wang K
    World J Surg Oncol; 2014 Dec; 12():367. PubMed ID: 25441176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of NF-κB by SOD2 promotes the aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated IKKβ expression.
    Chen PM; Wu TC; Wang YC; Cheng YW; Sheu GT; Chen CY; Lee H
    Carcinogenesis; 2013 Nov; 34(11):2655-63. PubMed ID: 23784082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of MADD in lung adenocarcinoma tissues and its effects on proliferation and apoptosis of lung adenocarcinoma A549 cells].
    Wei YP; Wu JX; Guo YF; Sun GY; Zhang Q; Bi WX; Dong L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):354-7. PubMed ID: 22482404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255.
    Tracy S; Mukohara T; Hansen M; Meyerson M; Johnson BE; Jänne PA
    Cancer Res; 2004 Oct; 64(20):7241-4. PubMed ID: 15492241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
    Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
    Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma.
    Shih JY; Tsai MF; Chang TH; Chang YL; Yuan A; Yu CJ; Lin SB; Liou GY; Lee ML; Chen JJ; Hong TM; Yang SC; Su JL; Lee YC; Yang PC
    Clin Cancer Res; 2005 Nov; 11(22):8070-8. PubMed ID: 16299238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of CUG-binding protein 1 expression and vascular invasion after radical surgery for stage IB nonsmall cell lung cancer.
    Zhao J; Zhao Y; Xuan Y; Jiao W; Qiu T; Wang Z; Luo Y
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e125-9. PubMed ID: 26728670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sirt3 is a tumor suppressor in lung adenocarcinoma cells.
    Xiao K; Jiang J; Wang W; Cao S; Zhu L; Zeng H; Ouyang R; Zhou R; Chen P
    Oncol Rep; 2013 Sep; 30(3):1323-8. PubMed ID: 23842789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms.
    Garrido G; Rabasa A; Garrido C; López A; Chao L; García-Lora AM; Garrido F; Fernández LE; Sánchez B
    Oncogene; 2014 Jun; 33(24):3129-39. PubMed ID: 23975426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of α-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer.
    Yoshii H; Ito K; Asano T; Horiguchi A; Hayakawa M; Asano T
    Oncol Rep; 2013 Sep; 30(3):1073-80. PubMed ID: 23817592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.
    Zhi X; Wang Y; Yu J; Yu J; Zhang L; Yin L; Zhou P
    IUBMB Life; 2012 Nov; 64(11):911-20. PubMed ID: 23086814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer.
    Chen B; Tang H; Liu X; Liu P; Yang L; Xie X; Ye F; Song C; Xie X; Wei W
    Cancer Lett; 2015 Jan; 356(2 Pt B):410-7. PubMed ID: 25304371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DACH1 inhibits the proliferation and invasion of lung adenocarcinoma through the downregulation of peroxiredoxin 3.
    Zhu J; Wu C; Li H; Yuan Y; Wang X; Zhao T; Xu J
    Tumour Biol; 2016 Jul; 37(7):9781-8. PubMed ID: 26810067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ubiquitin C-terminal Hydrolase 37, a novel predictor for hepatocellular carcinoma recurrence, promotes cell migration and invasion via interacting and deubiquitinating PRP19.
    Fang Y; Fu D; Tang W; Cai Y; Ma D; Wang H; Xue R; Liu T; Huang X; Dong L; Wu H; Shen X
    Biochim Biophys Acta; 2013 Mar; 1833(3):559-72. PubMed ID: 23220010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteopontin as a potential biomarker of proliferation and invasiveness for lung cancer.
    Zhao B; Sun T; Meng F; Qu A; Li C; Shen H; Jin Y; Li W
    J Cancer Res Clin Oncol; 2011 Jul; 137(7):1061-70. PubMed ID: 21207061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Significance of CDCP1 Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion and Migration.
    Chou CT; Li YJ; Chang CC; Yang CN; Li PS; Jeng YM; Chen ST; Kuo ML; Lin IC; Lin BR
    Ann Surg Oncol; 2015 Dec; 22(13):4335-43. PubMed ID: 25820997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p190 RhoGAP promotes contact inhibition in epithelial cells by repressing YAP activity.
    Frank SR; Köllmann CP; Luong P; Galli GG; Zou L; Bernards A; Getz G; Calogero RA; Frödin M; Hansen SH
    J Cell Biol; 2018 Sep; 217(9):3183-3201. PubMed ID: 29934311
    [No Abstract]   [Full Text] [Related]  

  • 40. EGFR mediates activation of RET in lung adenocarcinoma with neuroendocrine differentiation characterized by ASCL1 expression.
    Bhinge K; Yang L; Terra S; Nasir A; Muppa P; Aubry MC; Yi J; Janaki N; Kovtun IV; Murphy SJ; Halling G; Rahi H; Mansfield A; de Andrade M; Yang P; Vasmatzis G; Peikert T; Kosari F
    Oncotarget; 2017 Apr; 8(16):27155-27165. PubMed ID: 28460442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.